The aim of this study was to evaluate vaccine efficacy of a commercial vaccine STARTVAC® aimed at reducing intramammary infections (IMI) with Staphylococcus aureus and coagulase-negative staphylococci under field conditions.

Über diesen Artikel

Verfasser

Zusammenfassung

The utilization of vaccine in combination with
other infection-control procedures, such as excellent
milking procedures, treatment, segregation, and culling
of known infected cattle, will result in an important
reduction in incidence and duration of intramammary
staphylococcal infections.